UM organiza o primeiro Fórum Internacional de Macau sobre Ciência Regulamentar Farmacêutica

The inaugural ‘Macau International Forum on Pharmaceutical Regulatory Science’, hosted by the Institute of Chinese Medical Sciences (ICMS) of the University of Macau (UM) and organised by the Centre for Pharmaceutical Regulatory Sciences (CPRS), UM, was held at UM. Themed ‘High-quality Development of Chinese Medicines: Theory and Practice’, the forum brought together over 130 renowned experts, scholars, policymakers, researchers, and students from home and abroad to discuss the latest advances in pharmaceutical regulatory science, and to share insights on the commercialisation of research results, regulation, and coordinated development of the ‘big health’ industry, thereby promoting the growth of the industry.

The forum began with opening remarks by Chen Xin, director of ICMS and the State Key Laboratory of Quality Research in Chinese Medicine. Hu Yuanjia, director of CPRS, then gave an overview of the centre’s development. The forum consisted of two sessions, the first moderated by Professor Hu Hao and Assistant Professor Li Chihua in ICMS, and the second moderated by Associate Professor Ouyang Defang in ICMS. The panel discussions were moderated by Director Hu Yuanjia and Deputy Director Ung Oi Lam of CPRS and Associate Professor Bian Ying in ICMS. Throughout the event, more than 20 experts shared their insights on how to use pharmaceutical regulatory science to advance the Chinese medicine and ‘big health’ industries.